Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
05/15/2013 | EP2590657A1 Organic compounds |
05/15/2013 | EP2590652A1 Pharmaceutical compositions containing vanoxerine |
05/15/2013 | EP2590650A2 Pharmaceutical compositions including carbamoyloxy arylalkanoyl arylpiperazine compound |
05/15/2013 | EP2590647A2 Pro-neurogenic compounds |
05/15/2013 | EP2590645A2 Methods for treating bipolar disorder |
05/15/2013 | EP2590636A1 Novel gastro- retentive dosage forms comprising a gaba analog and an opioid |
05/15/2013 | CN103108882A Polycrystalline type object of CDDO BIEA and use thereof |
05/15/2013 | CN103108864A Arylosulfonamides for the treatment of cns diseases |
05/15/2013 | CN103108650A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases |
05/15/2013 | CN103108647A Brain function enhancement composition and method for enhancing brain function |
05/15/2013 | CN103108646A Composition for improving brain function and method for improving brain function |
05/15/2013 | CN103108637A Methods of intravenous administration of glyburide and other drugs |
05/15/2013 | CN103108633A Trkb agonists and methods of use |
05/15/2013 | CN103102393A Polypeptide and application of polypeptide in preparation of drug used for treating depression |
05/15/2013 | CN103102359A Pyrimidine compounds and application thereof |
05/15/2013 | CN103102349A Protein kinase inhibitor and composition and application thereof |
05/15/2013 | CN103102314A Benzothiazole, benzimidazole, benzoxazole derivatives and preparation method and application thereof |
05/15/2013 | CN103100069A Adenophora stricta tablets for clearing heat and eliminating phlegm |
05/15/2013 | CN103100066A Traditional Chinese medicine composition for tranquilizing and allaying excitement and preparation method thereof |
05/15/2013 | CN103100040A Traditional Chinese medicine pill for treating hysteria |
05/15/2013 | CN103100039A Traditional Chinese medicine pill for treating yin-deficiency and fire-hyperactivity type insomnia |
05/15/2013 | CN103100036A Traditional Chinese medicine (TCM) preparation for treating intercostal neuralgia |
05/15/2013 | CN103100031A Chinese herbal medicine for treating insomnia caused by yin deficiency of liver and kidney |
05/15/2013 | CN103100029A Wu houshan bitter tea |
05/15/2013 | CN103100019A Body-building, brain-strengthening and kidney-nourishing agent |
05/15/2013 | CN103099972A Traditional Chinese medicine composition for treating restlessness after craniocerebral trauma operation and preparation method of traditional Chinese medicine composition |
05/15/2013 | CN103099971A Chinese medicinal composition for treating vascular vertigo |
05/15/2013 | CN103099970A Chinese herbal medicine for treating trigeminal neuralgia |
05/15/2013 | CN103099969A Pharmaceutical composition for treating nervous headache |
05/15/2013 | CN103099944A Drug for treating stubborn insomnia |
05/15/2013 | CN103099942A Drug for treating insomnia and preparation method thereof |
05/15/2013 | CN103099919A Chaixiang (Chinese character) liver tablets |
05/15/2013 | CN103099911A Application of mental treasure pills in preparation of medicine for treating senile dementia |
05/15/2013 | CN103099893A Traditional Chinese medicine oral liquid for treating insomnia |
05/15/2013 | CN103099889A Traditional Chinese medicine wine for treating lumbar spinal stenosis |
05/15/2013 | CN103099888A Foot massage bag for eliminating fatigue, improving sleep and enhancing physical strength and preparation technology of foot massage bag |
05/15/2013 | CN103099872A Chinese herbal medicine for treating headaches caused by internal liver heat and external cold |
05/15/2013 | CN103099866A Traditional Chinese medicine composition for treating anxiety and insomnia and preparation method thereof |
05/15/2013 | CN103099858A Traditional Chinese medicine combination and application |
05/15/2013 | CN103099847A Formula of traditional Chinese medicine for treating neurasthenia |
05/15/2013 | CN103099839A Rapid drying and storing method for keeping levodopa content of broad bean flowers |
05/15/2013 | CN103099832A Method for biotransformation of pseudo-ginseng by using Candida |
05/15/2013 | CN103099802A Application of salvianolic acid A composition in preparation of medicine for salvaging ischemic penumbra |
05/15/2013 | CN103099801A Application of 13-methyitetradecanoic acid in preparation of medicine for treating focal cerebral ischemia |
05/15/2013 | CN102552714B Plaster for treating facial neuroparalysis and rheumatic arthritis |
05/15/2013 | CN102406778B Traditional Chinese medicine composition for treating Alzheimer type dementia and preparation method thereof |
05/15/2013 | CN102327464B Medicament for treating insomnia |
05/15/2013 | CN102319406B Medicament for treating tristimania |
05/15/2013 | CN102294010B Medicine with functions of strengthening body resistance and eliminating depression and its production method |
05/15/2013 | CN102283828B Application of tetrahydroxybenzopyrone compound |
05/15/2013 | CN102283823B Application of tetrahydroxy propenone compounds |
05/15/2013 | CN102204908B Pharmaceutical composition containing edaravone compound, and preparation method thereof |
05/15/2013 | CN102140467B Human miR-365 antisense nucleic acid and application thereof |
05/15/2013 | CN102076671B Triazole derivative or salt thereof |
05/15/2013 | CN102060921B High-stability VPAC2 type receptor specific activator MHDBAY, preparation method and application thereof |
05/15/2013 | CN102046639B New classes of GABAA/BzR ligands |
05/15/2013 | CN101869157B Health-care composition (Parkinson-resistant shockproof health-care tea) for preventing and treating PD (Parkinson Disease) and preparation method thereof |
05/15/2013 | CN101820755B Anti-inflammatory compounds and uses thereof |
05/15/2013 | CN101772494B 4-pyrimidinesulfamide derivative |
05/15/2013 | CN101486713B Furo[2,3-h] chromene compound and use for preventing platelet aggregation |
05/15/2013 | CN101171927B Choline-silicic acid complex with osmolytes and divalent trace elements |
05/14/2013 | US8440694 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor |
05/14/2013 | US8440678 Pharmaceutical composition |
05/14/2013 | US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes |
05/14/2013 | US8440666 Pyridazinone compounds and P2X7 receptor inhibitors |
05/14/2013 | US8440644 Compounds as receptor modulators with therapeutic utility |
05/14/2013 | US8440623 Polymer stabilized neuropeptides |
05/14/2013 | US8440621 Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels |
05/14/2013 | US8440615 Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase |
05/14/2013 | US8440232 Methods of treatment using a gastric retained gabapentin dosage |
05/14/2013 | US8440220 Sustained release of drug antagonist; analgesic reservoir, barrier layer |
05/14/2013 | US8440204 Subtype of Closteridium botulinum neurotoxin type A and uses thereof |
05/14/2013 | CA2716369C Phenoxypropylamine compounds |
05/14/2013 | CA2655959C Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
05/14/2013 | CA2583550C Thienopyridines as allosteric potentiators of the m4 muscarinic receptor |
05/14/2013 | CA2583333C Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
05/14/2013 | CA2580250C Loxapine analogs and methods of use thereof |
05/14/2013 | CA2579353C Therapeutic strategy for treating autoimmune and degenerative diseases |
05/14/2013 | CA2556383C Use of n-piperidine derivatives for the treatment of neurodegenerative pathologies |
05/14/2013 | CA2555463C Inhibitors of tgf-r signaling for treatment of cns disorders |
05/14/2013 | CA2532965C 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
05/14/2013 | CA2506647C Method for digesting proteins highly resistant to denaturation and degradation |
05/14/2013 | CA2497572C Akt inhibitors, pharmaceutical compositions, and uses thereof |
05/14/2013 | CA2465753C Orodispersible tablet having high homogeneity and the preparation method thereof |
05/14/2013 | CA2460352C Composition and transdermal drug delivery device |
05/10/2013 | WO2013067483A1 Delivery systems for improving oral bioavailability of fenobam, its hydrates, and salts |
05/10/2013 | WO2013067434A1 Pak inhibitors for the treatment of fragile x syndrome |
05/10/2013 | WO2013067415A1 Identification and use of protease inhibitors to treat or prevent sickle cell disease |
05/10/2013 | WO2013067362A1 Midbrain dopamine (da) neurons for engraftment |
05/10/2013 | WO2013067248A1 Benzoxazines as modulators of ion channels |
05/10/2013 | WO2013067157A1 Compositions and methods for reduction of amyloid-beta load |
05/10/2013 | WO2013067125A1 Co-activation of mtor and stat3 pathways to promote neuronal survival and regeneration |
05/10/2013 | WO2013067084A1 Silylated azulenyl nitrone spin traps as chromotropic superoxide detectors |
05/10/2013 | WO2013066869A1 Piperidinyl-substituted lactams as gpr119 modulators |
05/10/2013 | WO2013066181A1 Imaging ligands |
05/10/2013 | WO2013066168A1 Composition for improving neuropsychological test battery score |
05/10/2013 | WO2013066167A1 Method for improving executive function |
05/10/2013 | WO2013066165A1 Improving recognition |
05/10/2013 | WO2013066153A1 Composition for improving neuropsychological test battery score |
05/10/2013 | WO2013066152A1 Method for improving executive function |